ALFA FinderNSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.
Alkem Laboratories Ltd: key numbers
- Share price
- ₹5,218.00
- Market cap
- ₹62,389 Cr
- Revenue (annual)
- ₹14,712 Cr
- Net profit (annual)
- ₹2,302 Cr
- P/E (TTM)
- 28.9×Sector 43.8×
- Promoter holding
- 49.70%+0.00% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkem Laboratories Ltd
All →Alkem Laboratories Results Update
Alkem posted Q2FY27 revenue of ₹4,552 Cr, up 14% YoY, with 22.5% EBITDA margin. Net profit fell 11.7% to ₹675 Cr on higher R&D.
Alkem Laboratories Q2 FY27 Results: Net Profit ₹667.1 Cr, Down 14.4% YoY
Alkem Laboratories Ltd reported revenue from operations of ₹4,552 Cr (+13.8% YoY) and net profit of ₹667.1 Cr (-14.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹667.1 Cr · -14.4% YoY
Alkem Laboratories Merger & Restructuring Worth ₹9.56 Cr
Alkem incorporated a Saudi Arabian joint venture subsidiary, Alkem Pharma Company LLC, on 8 November 2026. It holds 51% after subscribing SAR 38.25 lakh, about ₹9.56 Crore.
- Value
- ₹9.56 Cr
Alkem Laboratories Board Meeting Date
Alkem Laboratories has scheduled its Board meeting for 12 Nov 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.
Alkem Laboratories Management Change
Alkem Laboratories appointed Dr. Amrut Naik as CEO effective November 11, 2026. The Board designated him as Key Managerial Personnel at its November 3 meeting.
Alkem Laboratories Business Update
Alkem informed the exchange that US FDA completed inspection of its Mandva API facility with no Form 483 observations. The clean result confirms regulatory compliance.
Other management change announcements
All →Harshdeep Hortico Management Change
Harshdeep Hortico's secretarial auditors, Dilip Swarnkar & Associates, resigned effective November 12, 2026. The resignation was due to pre-occupation with other professional commitments.
Nalwa Sons Investments Management Change
Nalwa Sons appoints Ajay Mittal as Chief Compliance Officer alongside his role as Company Secretary. The change is effective November 20, 2026.
Rubfila International Management Change
Rubfila International's board re-appointed Mr. G. Krishna Kumar as Managing Director for three years from 1 November 2026. The appointment is subject to shareholder approval.
- Execution
- three years
Ekam Leasing & Finance Company Management Change
Ekam Leasing CFO Rajeev Shukla resigned effective November 11, 2026, citing personal reasons. The resignation was accepted by the Board.
Canara HSBC Life Insurance Company Management Change
Canara HSBC Life appointed Mr Indu Swaroop as CFO effective 25 Nov 2026, succeeding Mr Tarun Rustagi who resigned. The change designates Swaroop as KMP and Senior Management Personnel.
Aspire & Innovative Advertising Management Change
Aspire & Innovative Advertising accepted resignation of Independent Director Sudhanshu Singhal and appointed Ms. Pankila as Additional Director. The board confirmed both changes on November 12, 2026.